[ET Net News Agency, 20 July 2021] GENSCRIPT BIO (01548) rose 2.5% to HK$43.
It hits an intra-day high of HK$43, hitting a historical high, and an intra-day low of
HK$41.2. The total shares traded was 1.5 million, with a value of HK$63.8m. The active
buy/sell ratio is 76:24, with net buying turnover of HK$30.79m. GOLDMAN SACHS (ASIA) SEC
accounts for greatest net responsive buying turnover of HK$875,492, with volume weighted
average price of HK$42.47. CREDIT SUISSE (HK) SEC accounts for greatest net responsive
selling turnover of HK$5.3m, with volume weighted average price of HK$42.741. The stock
has risen a combined 14.67% over the past 5 consecutive trading days.
The Hang Seng Index now fell 68 points, or 0.25% to 27,421; the Hang Seng China
Enterprises Index now fell 20 points, or 0.2% to 9,938; the Hang Seng TECH Index now rose
6 points, or 0.09% to 7,438; with an overall turnover of HK$11.2b.
The SSE Composite Index now fell 17 points, or 0.49% to 3,521, with an overall turnover
of RMB53.08b.
The SZSE Component Index now fell 12 points, or 0.09% to 14,979, with an overall
turnover of RMB35.12b.
Basic Information
-------------------------------------------
Nominal 43.000 % Chg +2.50%
High 43.000 Low 41.200
Shares Tr 1.5m Turnover 63.8m
10-D SMA 38.675 %H.V 72.733
20-D SMA 36.385 VWAP 42.486
50-D SMA 31.273 RSI14 74.134
-------------------------------------------
Status: Hitting a historical high, active buy/sell ratio is 76:24, with net buying
turnover of HK$30.79m, rising a combined 14.67% over the past 5 consecutive
trading days
Table: Performance of stocks in the same sector or of relevance
Stock (Code) Price(HK$) Change(%)
-------------------------------------------------
GENSCRIPT BIO (01548) 43.00 +2.50
INNOVENT BIO (01801) 90.85 +0.28
JXR (01951) 16.38 +0.99
WUXI BIO (02269) 140.50 +0.64
CSTONE PHARMA-B (02616) 17.06 -3.07
CANSINOBIO-B (06185) 323.20 +2.08
HAOHAI BIOTEC (06826) 107.70 -0.37
ASCENTAGE-B (06855) 49.10 +3.37
KINTOR PHARMA-B (09939) 73.30 -0.95
KINDSTAR GLOBAL (09960) 8.52 +3.90
-------------------------------------------------
(ed)